Dimerix Limited ( (AU:DXB) ) has provided an update.
Dimerix Limited has announced the quotation of 5,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code DXB, effective April 10, 2025. This move reflects the company’s ongoing efforts to enhance its financial flexibility and strengthen its market presence, potentially benefiting stakeholders by increasing liquidity and visibility in the market.
More about Dimerix Limited
Dimerix Limited operates in the biotechnology industry, focusing on the development of innovative pharmaceutical products. The company is primarily engaged in creating treatments for unmet medical needs, with a particular emphasis on kidney and respiratory diseases.
YTD Price Performance: 7.35%
Average Trading Volume: 2,027,843
Technical Sentiment Signal: Sell
Current Market Cap: A$198.5M
Find detailed analytics on DXB stock on TipRanks’ Stock Analysis page.